E
Appili Therapeutics Inc. APLIF
OTC PK
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Good
Efficiency Index Very Weak
Solvency Index Weak
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Beta 1.08
Price History APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -3.60%
30-Day Total Return 9.18%
60-Day Total Return -19.25%
90-Day Total Return -23.57%
Year to Date Total Return -17.05%
1-Year Total Return -32.06%
2-Year Total Return -74.97%
3-Year Total Return -97.33%
5-Year Total Return --
52-Week High % Change -68.48%
52-Week Low % Change 46.91%
Price APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $0.08
52-Week Low Price $0.02
52-Week Low Price (Date) Feb 20, 2024
52-Week High Price (Date) Jul 18, 2023
Valuation APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 2.69M
Enterprise Value 8.16M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.03
Earnings Per Share Growth -60.86%
Price/Earnings To Growth --
Price/Sales (TTM) 3.40
Price/Book (Q) -0.39
Enterprise Value/Revenue (TTM) 10.11
Price $0.02
Enterprise Value/EBITDA (TTM) -1.39
Enterprise Value/EBIT -1.38
Market Cap Category Nano Cap
Dividends and Shares APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 121.27M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 902-442-4655
Address #21-1344 Summer Street Halifax, NS B3H 0A8
Website www.appilitherapeutics.com
Country Canada
Year Founded 2015
Profitability APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -730.03%
Profit Margin -465.76%
Management Effectiveness APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -228.01%
Return on Equity --
Income Statement APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 850.20K
Total Revenue (TTM) 850.20K
Revenue Per Share $0.01
Gross Profit (TTM) 850.20K
EBITDA (TTM) -6.20M
EBIT (TTM) -6.21M
Net Income (TTM) -3.96M
Net Income Avl. to Common (TTM) -3.96M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 94.20%
EPS Diluted (TTM) -0.03
EPS Diluted Growth (Q YOY) 94.34%
Balance Sheet APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 456.50K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 1.46M
Total Preferred Equity (Q) --
Total Equity (Q) -7.44M
Current Ratio (Q) 0.460
Book Value Per Share (Q) -$0.06
Total Assets (Q) 1.49M
Total Current Liabilities (Q) 3.19M
Total Debt (Q) 6.07M
Total Liabilities (Q) 8.94M
Total Common Equity (Q) -7.44M
Cash Flow APLIF - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -27.00K
Cash from Financing (TTM) 1.72M
Net Change in Cash (TTM) -621.00K
Levered Free Cash Flow (TTM) -3.39M
Cash from Operations (TTM) -2.32M
Weiss Ratings